Koyfin Home > Directory > Health Care > Arcus Biosciences Inc

Arcus Biosciences Inc Price Chart RCUS

Historical daily share price chart and data for Arcus Biosciences Inc since 2018 adjusted for splits and dividends. The latest closing price for Arcus Biosciences Inc as of October 11, 2019 is $8.2.
  • In 2019 the stock opened at $10.55 and closed at $8.20 for a loss of -29% YTD.
  • In 2018 the stock opened at $20.00 and closed at $10.77 for a loss of -86%.
View Chart On Koyfin

Arcus Biosciences Inc Summary

Stock Symbol: RCUS

Arcus Biosciences Inc Company Info

Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing cancer immunotherapies in the United States. The company develops various programs targeting immuno-oncology pathways, including AB928, a dual adenosine receptor antagonist, which is in a Phase I/Ib clinical trial; and AB122, an anti-PD-1 antibody that is in Phase I clinical trial. It is also developing AB154, an anti-T-cell immunoreceptor with Ig and ITIM domains antibody, which is in Phase I trial as monotherapy; and AB680, a small-molecule inhibitor of CD73 that is in Phase I healthy volunteer study. The company has a clinical development collaboration agreement with Strata Oncology, Inc. to evaluate AB122, an anti-PD-1 antibody. Arcus Biosciences, Inc. was founded in 2015 and is headquartered in Hayward, California.
Market Cap
376m
Dividend Yield
0 %
Beta vs SPX
1.5
Short Interest
180.71 %
30D Volatility
84.44
Hedge Fund Held
0 %
Competitors

Last 10 Days of RCUS Prices

10/11/2019$8.20
10/10/2019$8.00
10/09/2019$7.97
10/08/2019$8.13
10/07/2019$8.20
10/04/2019$8.79
10/03/2019$8.63
10/02/2019$8.17
10/01/2019$8.60
09/30/2019$9.10